by ODWAdmin | Sep 16, 2025 | Uncategorized
One of the most challenging aspects of radioligand therapy (RLT) development is understanding why initially responsive tumors eventually develop resistance to treatment. While imaging can show when treatments stop working, it cannot reveal the underlying molecular...
by ODWAdmin | Sep 8, 2025
Combining Metabolomics, Proteomics and Transcriptomics to Reveal Key Pathways and Biomarkers Explore how reduced KRAS activity reshapes gene expression and pathway activity in HCT-116 cells. In this application note, Panome Bio combines next-generation metabolomics,...
by Jason Heaviland | Aug 22, 2025 | Uncategorized
Why Quality Systems Matter More Than You Think When you’re deeply immersed in assay development or screening potential biomarkers, regulatory compliance might understandably feel like an afterthought, given that your primary focus necessarily gravitates toward...
by ODWAdmin | Jun 24, 2025
This sample data report features an integrated analysis of untargeted metabolomics and proteomics datasets. Learn how Panome Bio provides cultured meat researchers with novel insights into their cell culture systems.
by ODWAdmin | May 27, 2025
This sample data report characterizes global changes in gene expression and pathway activity due to reduced KRAS activity in HCT-116 cells. Learn how Panome Bio utilizes mRNA Sequencing, Next-Generation Metabolomics, Global Proteomics, and Phosphoproteomics data to...
